Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma.

The aim of the study was to evaluate the prognostic value of the vascular endothelial growth factor A (VEGF-A) and hepatocyte growth factor receptor (HGFR, c-met) expressions in homogenous group of breast cancer patients. Tumor samples were collected from 98 patients with invasive ductal breast carc...

Full description

Bibliographic Details
Main Authors: Aleksandra Łacko, Ewelina Łata, Jolanta Szelachowska, Agnieszka Hałoń, Elzbieta Suder, Rafał Matkowski, Iwona Gisterek, Przemysław Biecek, Jan Kornafel
Format: Article
Language:English
Published: Via Medica 2010-06-01
Series:Folia Histochemica et Cytobiologica
Online Access:http://czasopisma.viamedica.pl/fhc/article/view/4241
id doaj-6fcc30eb277f45998039187f6d276034
record_format Article
spelling doaj-6fcc30eb277f45998039187f6d2760342020-11-24T22:23:05ZengVia MedicaFolia Histochemica et Cytobiologica0239-85081897-56312010-06-01481788310.5603/4241Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma.Aleksandra ŁackoEwelina ŁataJolanta SzelachowskaAgnieszka HałońElzbieta SuderRafał MatkowskiIwona GisterekPrzemysław BiecekJan KornafelThe aim of the study was to evaluate the prognostic value of the vascular endothelial growth factor A (VEGF-A) and hepatocyte growth factor receptor (HGFR, c-met) expressions in homogenous group of breast cancer patients. Tumor samples were collected from 98 patients with invasive ductal breast carcinoma stage II treated with primary surgery. We have observed a strong correlation between VEGF-A and c-met. No correlations were found between VEGF-A or HGFR expressions and clinical parameters (tumor size, grade, axillary lymph node status, age), 5- and 10-years DFS or OS. Our study did not reveal any prognostic value of c-met or VEGF. In addition they are not useful to separate a patients' subgroup with poor prognosis. Unlike in other authors' studies, our patients' group is very homogenous which might tribute to obtained results.http://czasopisma.viamedica.pl/fhc/article/view/4241
collection DOAJ
language English
format Article
sources DOAJ
author Aleksandra Łacko
Ewelina Łata
Jolanta Szelachowska
Agnieszka Hałoń
Elzbieta Suder
Rafał Matkowski
Iwona Gisterek
Przemysław Biecek
Jan Kornafel
spellingShingle Aleksandra Łacko
Ewelina Łata
Jolanta Szelachowska
Agnieszka Hałoń
Elzbieta Suder
Rafał Matkowski
Iwona Gisterek
Przemysław Biecek
Jan Kornafel
Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma.
Folia Histochemica et Cytobiologica
author_facet Aleksandra Łacko
Ewelina Łata
Jolanta Szelachowska
Agnieszka Hałoń
Elzbieta Suder
Rafał Matkowski
Iwona Gisterek
Przemysław Biecek
Jan Kornafel
author_sort Aleksandra Łacko
title Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma.
title_short Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma.
title_full Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma.
title_fullStr Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma.
title_full_unstemmed Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma.
title_sort correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-a in breast carcinoma.
publisher Via Medica
series Folia Histochemica et Cytobiologica
issn 0239-8508
1897-5631
publishDate 2010-06-01
description The aim of the study was to evaluate the prognostic value of the vascular endothelial growth factor A (VEGF-A) and hepatocyte growth factor receptor (HGFR, c-met) expressions in homogenous group of breast cancer patients. Tumor samples were collected from 98 patients with invasive ductal breast carcinoma stage II treated with primary surgery. We have observed a strong correlation between VEGF-A and c-met. No correlations were found between VEGF-A or HGFR expressions and clinical parameters (tumor size, grade, axillary lymph node status, age), 5- and 10-years DFS or OS. Our study did not reveal any prognostic value of c-met or VEGF. In addition they are not useful to separate a patients' subgroup with poor prognosis. Unlike in other authors' studies, our patients' group is very homogenous which might tribute to obtained results.
url http://czasopisma.viamedica.pl/fhc/article/view/4241
work_keys_str_mv AT aleksandrałacko correlationbetweenhepatocytegrowthfactorreceptorandvascularendothelialgrowthfactorainbreastcarcinoma
AT ewelinałata correlationbetweenhepatocytegrowthfactorreceptorandvascularendothelialgrowthfactorainbreastcarcinoma
AT jolantaszelachowska correlationbetweenhepatocytegrowthfactorreceptorandvascularendothelialgrowthfactorainbreastcarcinoma
AT agnieszkahałon correlationbetweenhepatocytegrowthfactorreceptorandvascularendothelialgrowthfactorainbreastcarcinoma
AT elzbietasuder correlationbetweenhepatocytegrowthfactorreceptorandvascularendothelialgrowthfactorainbreastcarcinoma
AT rafałmatkowski correlationbetweenhepatocytegrowthfactorreceptorandvascularendothelialgrowthfactorainbreastcarcinoma
AT iwonagisterek correlationbetweenhepatocytegrowthfactorreceptorandvascularendothelialgrowthfactorainbreastcarcinoma
AT przemysławbiecek correlationbetweenhepatocytegrowthfactorreceptorandvascularendothelialgrowthfactorainbreastcarcinoma
AT jankornafel correlationbetweenhepatocytegrowthfactorreceptorandvascularendothelialgrowthfactorainbreastcarcinoma
_version_ 1725765983807733760